Telmisartan Concept

subject area of

• Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials  Journal Articles
• Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials  Journal Articles
• Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes  Journal Articles
• Albuminuria and Rapid Loss of GFR and Risk of New Hip and Pelvic Fractures  Journal Articles
• Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)  Journal Articles
• Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?  Journal Articles
• Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study).  Journal Articles
• Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke  Journal Articles
• Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries  Journal Articles
• Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)  Journal Articles
• Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies  Journal Articles
• Cardiorenal effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET)  Journal Articles
• Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk  Journal Articles
• Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk  Journal Articles
• Control of vascular changes by renin–angiotensin–aldosterone system in salt-sensitive hypertension  Journal Articles
• Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus  Journal Articles
• Differences in Ischemic and Hemorrhagic Recurrence Rates among Race-Ethnic Groups in the PRoFESS Secondary Stroke Prevention Trial  Journal Articles
• Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies  Journal Articles
• Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke  Journal Articles
• Effect of Telmisartan on Renal Outcomes  Journal Articles
• Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial  Journal Articles
• Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes  Journal Articles
• Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease  Journal Articles
• Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study  Journal Articles
• Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease  Journal Articles
• Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals  Journal Articles
• Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial  Journal Articles
• Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy  Journal Articles
• Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both  Journal Articles
• From the hope to the ontarget and the transcend studies: challenges in improving prognosis  Journal Articles
• Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema  Journal Articles
• Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk  Journal Articles
• Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme  Journal Articles
• Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk  Journal Articles
• Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk  Journal Articles
• In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events  Journal Articles
• Is therapy of people with chronic kidney disease ONTARGET?  Journal Articles
• Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])  Journal Articles
• Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke  Journal Articles
• Metabolic effects of telmisartan in subjects with abdominal obesity: A prospective randomized controlled trial  Journal Articles
• Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study  Journal Articles
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Journal Articles
• Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials  Journal Articles
• Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention  Journal Articles
• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial  Journal Articles
• Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies  Journal Articles
• Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes  Journal Articles
• Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND)  Journal Articles
• Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk  Journal Articles
• Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease  Journal Articles
• Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events  Journal Articles
• Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events  Journal Articles
• Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data.  Journal Articles
• The Mini‐Mental State Examination, Clinical Factors, and Motor Vehicle Crash Risk  Journal Articles
• The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics  Journal Articles
• The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study  Journal Articles
• The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial  Journal Articles